We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-1.94%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$107B
AUM Growth
-$13.8B
Cap. Flow
-$14.2B
Cap. Flow %
-13.33%
Top 10 Hldgs %
9.28%
Holding
6,280
New
934
Increased
1,773
Reduced
2,078
Closed
805

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$384M
2
AAPL icon
Apple
AAPL
+$377M
3
PYPL icon
PayPal
PYPL
+$368M
4
PFE icon
Pfizer
PFE
+$339M
5
SCHW
Charles Schwab
SCHW
+$319M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.02B
2
XLNX
Xilinx Inc
XLNX
+$732M
3
NFLX icon
Netflix
NFLX
+$461M
4
C icon
Citigroup
C
+$361M
5
BKNG icon
Booking.com
BKNG
+$288M

Sector Composition

Rank Sector Weight
1 Technology 13.54%
2 Consumer Discretionary 9.06%
3 Financials 8.31%
4 Healthcare 8.05%
5 Communication Services 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFWM
4501
DELISTED
First Foundation Inc
FFWM
$292K ﹤0.01%
12,017
-15,264
-56% -$397K
CVCO icon
4502
Cavco Industries
CVCO
$4.46B
$291K ﹤0.01%
1,210
+446
+58% +$123K
DIBS icon
4503
1stdibs.com
DIBS
$152M
$291K ﹤0.01%
+36,457
New +$351K
CBIO
4504
Crescent Biopharma
CBIO
$681M
$291K ﹤0.01%
2,557
-122
-5% -$14.3K
O icon
4505
PUT
Realty Income
O
$59.1B
$291K ﹤0.01%
4,200
-50,200
-92% -$3.41M
BMBL icon
4506
CALL
Bumble
BMBL
$363M
$290K ﹤0.01%
10,000
HIMX
4507
Himax Technologies
HIMX
$2.41B
$290K ﹤0.01%
26,678
-353,124
-93% -$4.02M
DCRDW
4508
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$290K ﹤0.01%
500,000
FLIC
4509
DELISTED
First of Long Island Corp
FLIC
$289K ﹤0.01%
+14,872
New +$320K
SABR icon
4510
CALL
Sabre
SABR
$884M
$289K ﹤0.01%
25,300
-464,700
-95% -$4.55M
GERN icon
4511
Geron
GERN
$983M
$288K ﹤0.01%
+211,862
New +$236K
OFLX icon
4512
Omega Flex
OFLX
$273M
$288K ﹤0.01%
2,219
PERI icon
4513
Perion Network
PERI
$372M
$288K ﹤0.01%
12,789
-608
-5% -$13K
TIPT icon
4514
Tiptree Inc
TIPT
$682M
$288K ﹤0.01%
22,460
-26,018
-54% -$335K
DISCK
4515
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$287K ﹤0.01%
11,500
AIN icon
4516
Albany International
AIN
$1.67B
$286K ﹤0.01%
3,387
-30
-0.9% -$2.58K
TRVN
4517
DELISTED
Trevena, Inc.
TRVN
$285K ﹤0.01%
829
+439
+113% +$138K
OZON
4518
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$285K ﹤0.01%
+49,286
New +$1.04M
ABCL icon
4519
AbCellera Biologics
ABCL
$3.96B
$284K ﹤0.01%
29,097
-37,014
-56% -$350K
AQST icon
4520
Aquestive Therapeutics
AQST
$678M
$284K ﹤0.01%
108,838
+21,052
+24% +$61.5K
NPO icon
4521
Enpro
NPO
$6.51B
$284K ﹤0.01%
2,905
-200
-6% -$21.3K
ZWS icon
4522
Zurn Elkay Water Solutions
ZWS
$8.13B
$284K ﹤0.01%
+8,024
New +$267K
RLMD icon
4523
Relmada Therapeutics
RLMD
$490M
$283K ﹤0.01%
+10,487
New +$217K
THC icon
4524
Tenet Healthcare
THC
$22.3B
$283K ﹤0.01%
3,296
-8,606
-72% -$707K
IPSC icon
4525
Century Therapeutics
IPSC
$389M
$282K ﹤0.01%
22,437
+7,400
+49% +$98.1K

Similar funds

David Shaw's Q1 2022 Portfolio in Review

As of Q1 2022, David Shaw held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

David Shaw withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, David Shaw opened a new position in Cenovus Energy worth $141M.

  • David Shaw's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
  • David Shaw added most to Starbucks in Q1 2022, an estimated $384M increase.
  • David Shaw's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
  • David Shaw fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
  • David Shaw's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
  • David Shaw opened 934 new positions and closed 805 in Q1 2022.
  • David Shaw's portfolio value fell 11% quarter-over-quarter to $107B.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.